Miguel Madeira
Overview
Explore the profile of Miguel Madeira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa-Junior D, Souza Valente T, Rolim Belisario A, Carvalho G, Madeira M, Velloso-Rodrigues C
Mol Genet Metab Rep
. 2024 May;
39:101086.
PMID: 38800625
Objectives: Our study evaluated the association of the polymorphism rs724016 in the gene, previously associated with height in other populations, with predictors of height, clinical outcomes, and laboratory parameters in...
2.
Gehrke B, Alves Coelho M, Brasil dAlva C, Madeira M
Arch Endocrinol Metab
. 2023 Nov;
68:e220334.
PMID: 37948565
Bisphosphonates (BPs) are medications widely used in clinical practice to treat osteoporosis and reduce fragility fractures. Its beneficial effects on bone tissue have been consolidated in the literature for the...
3.
Gehrke B, Farias M, Wildemberg L, Ferraiuoli G, Ribeiro V, Bosgnoli R, et al.
Endocrine
. 2023 Sep;
83(1):214-226.
PMID: 37673836
Purpose: People living with the human immunodeficiency virus (PLWH) developed higher life expectancy along with chronic bone disease over the past years. Our purpose is to evaluate bone mineral density,...
4.
Santa Rosa R, Polonine S, Pichone A, Gomes C, Lima L, Paranhos Neto F, et al.
Endocrine
. 2023 Aug;
82(3):673-680.
PMID: 37624475
Purpose: This cross-sectional study aimed to assess bone mineral density (BMD), bone microarchitecture and fracture prevalence in women with chronic postsurgical hypoparathyroidism (hypoPT). Methods: Twenty-seven women with postsurgical hypoPT and...
5.
Silva B, Madeira M, Brasil dAlva C, Maeda S, de Holanda N, Ohe M, et al.
Arch Endocrinol Metab
. 2022 Oct;
66(5):591-603.
PMID: 36191263
Several drugs are available for the treatment of osteoporosis in postmenopausal women. Over the last decades, most patients requiring pharmacological intervention were offered antiresorptive drugs as first-line therapy, while anabolic...
6.
Lopes K, DE Souza M, da Costa Tavares Bezerra M, Bessa L, Farinatti P, Bouskela E, et al.
Trials
. 2022 Sep;
23(1):733.
PMID: 36056396
Background: Evidence of the benefits induced from resistance exercise on health markers of post-bariatric patients is limited. The study will investigate the effects of a resistance training (RT) program on...
7.
Oliveira F, Lima L, Paranhos Neto F, de Mendonca L, Schtscherbyna A, de Lima L, et al.
Clin Endocrinol (Oxf)
. 2022 Apr;
97(1):142-149.
PMID: 35484952
Objective: Combination antiretroviral treatment (cART) allows for longer survival for people living with HIV and hence long-term complications of both disease and treatment are common. Our purpose was to evaluate...
8.
Sant Ana I, Torrini R, Alves Coelho M, Cantoni J, Madeira M, Ribeiro M
Mol Genet Genomic Med
. 2022 Apr;
10(6):e1941.
PMID: 35384411
Background: X-linked hypophosphatemic rickets (XLHR) is a rare genetic disease, often delayed in diagnosis due to the low degree of suspicion and limited access to sophisticated diagnostic tools that confirm...
9.
Pichone A, Gomes C, Lima L, Moreira C, Paranhos-Neto F, Madeira M, et al.
Bone Rep
. 2022 Feb;
16:101173.
PMID: 35198659
Patients with end-stage renal disease develop changes in bone quality and quantity, which can be assessed using different methods. This study aimed to compare and to correlate bone parameters obtained...
10.
Gomez O, Paez-Talero A, Zanchetta M, Madeira M, Moreira C, Campusano C, et al.
Arch Osteoporos
. 2021 Dec;
17(1):3.
PMID: 34888731
No abstract available.